z-logo
open-access-imgOpen Access
The Value of Topotecan in the Second-Line Treatment of Small-Cell Lung Cancer. Preliminary Report
Author(s) -
Beata Biernacka,
Paweł Krawczyk,
Jarosław Buczkowski,
Anna Siwiec,
Katarzyna Perżyło,
Li Wang
Publication year - 2010
Publication title -
advances in respiratory medicine
Language(s) - English
Resource type - Journals
eISSN - 2543-6031
pISSN - 2451-4934
DOI - 10.5603/arm.27726
Subject(s) - topotecan , medicine , oncology , performance status , hazard ratio , chemotherapy , lung cancer , regimen , proportional hazards model , disease , chemotherapy regimen , malignancy , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here